Key result
Baseline depressive symptoms and cognitive function predicted significant deterioration over 12 months, with GDS-15 scores increasing (Cohen-d 0.542) and MMSE scores decreasing (Cohen-d 0.216).
Why the study?
Changes in cognitive function and mental health with aging burden public health systems, but their progression needed examination in Brazilian primary care older adults.
Observational (n=368)
No
Standardized Mean Difference: 0.542
p-value: p=0.048
In Brazilian older adults attending primary care, depressive symptoms and cognitive decline significantly worsened over a 1-year period, with baseline levels predicting the extent of deterioration.
Depressive symptoms worsened and cognition declined over 12 months in primary care; leaves open need for prospective trials on monitoring strategies.
Background: Aging is a global phenomenon closely associated with changes in cognitive function and mental health. These conditions substantially burden public health systems and adversely affect the quality of life of older adults. This study aimed to examine changes in depressive symptoms and cognitive function over a 12-month follow-up period in a cohort of Brazilian older adults attending primary care. Methods: This observational longitudinal study included a randomized sample of individuals aged ≥60 years residing in São Paulo, Brazil, and registered at a Primary Healthcare Unit (PHU). Data collection involved administering a sociodemographic and health questionnaire along with two validated instruments: the Geriatric Depression Scale-15 (GDS-15) and the Mini-Mental State Examination (MMSE). Linear regression models were used for the analyses. Results: A total of 368 older adults were included, with 63% being men and a mean age of 74.65 years. After one year, depressive symptoms showed a notable increase, with the mean GDS-15 score rising from 5.97 to 7.48 (Cohen-d = 0.542). Likewise, there was a decrease in the mean MMSE score ranging from 19.11 to 18.88 (Cohen-d = 0.216). Adjusted regression analyses revealed that depressive symptoms at baseline (B = 0.696; p = 0.048; R2 = 0.19) and cognitive function at baseline (B = 0.444; p < 0.001; R2 = 0.26) were predictive of their respective deteriorations over the follow-up period. Conclusions: Depressive symptoms and cognitive decline place a significant burden on public health systems in aging societies. These findings underscore the importance of continuous monitoring and early intervention strategies to mitigate their impact and enhance the quality of life for older adults.
No takes yet. Share an insight, caveat, or question.
Rivoli et al. (2025) conducted an observational in Depressive symptoms and cognitive decline (n=368). Baseline depressive symptoms and cognitive function was evaluated on Change in depressive symptoms (GDS-15) and cognitive function (MMSE) (Cohen-d 0.542, p=0.048). Baseline depressive symptoms and cognitive function predicted significant deterioration over 12 months, with GDS-15 scores increasing (Cohen-d 0.542) and MMSE scores decreasing (Cohen-d 0.216).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: